Meet with Abbott Presentation and Q&A December 14, 2011

Emerging companies find it increasingly difficult to reach the right person when seeking funding and/or partners. Through the Meet with Series, we provide emerging companies with greater access to partnering and/or financing opportunities.

In this session, senior members from Abbott's team will talk to potential partners or licensees to first explain what they are looking for in collaborations, particularly, to enable preclinical drug discovery and diagnostics.

Preclinical Pharmaceutical Interests

* Immunology (rheumatoid arthritis, osteoarthritis)
* Neuroscience (schizophrenia, neurodegenerative diseases)
* Pain (pain associated osteoarthritis, post-operative, neuropathic states and cancer)
* Oncology (novel targets and mechanisms described in brochure)
* Renal Diseases (diabetic nephropathy and chronic kidney disease)
* Biologics
* Enabling Drug Discovery Technologies and Drug Delivery approaches

Diagnostics Interests

* Next Generation Sequencing Technology
* Nucleic Acid Sample Preparation Technology
* Microfluidics (including immunodiagnostics, Point of Care, Hematology and molecular diagnostic applications)
* Label Free detection based BioSensors for nucleic acid and immunoassay applications

Speakers
Dr. Don Halbert - Division VP Abbott Bioresearch, Redwood City Abbott
Dr. Neela Patel - Director, External Research - West Coast Abbott
[Tentative] Dr. Jeff Huff - Director, New Technology Assessment, Diagnostics Abbott

Additional Abbott Attendees:
Murali Gopalakrishnan, Head, Global External Research
Bill Kohlbrenner, Director, Global External Research
Chuck Kunsch, Director, Global External Research (Immunology, Biologics)
Dieter Ziegler, Director, Global External Research (Neuroscience, Renal)
Daryl Sauer, Snr Group Leader, Global External Research (Enabling Technologies)
Nicole Walker, Abbott Biotech Ventures

Official Website: http://www.sjbiocenter.com/event/ev_2011Q4-MeetwithAbbott